Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020

Markos Kalligeros; Athanasios Vassilopoulos; Stephanos Vassilopoulos; David W. Victor; Eleftherios Mylonakis; Mazen Noureddin

doi:10.1016/j.cgh.2023.11.003

Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020

Markos Kalligeros, Athanasios Vassilopoulos, Stephanos Vassilopoulos, David W. Victor, Eleftherios Mylonakis, Mazen Noureddin

Research output: Contribution to journal › Short survey › peer-review

5 Scopus citations

Original language	English (US)
Journal	Clinical Gastroenterology and Hepatology
DOIs	https://doi.org/10.1016/j.cgh.2023.11.003
State	Accepted/In press - 2023

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1016/j.cgh.2023.11.003

Cite this

@article{e29bf984db0646bda41a33b7dd240422,

title = "Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020",

author = "Markos Kalligeros and Athanasios Vassilopoulos and Stephanos Vassilopoulos and Victor, {David W.} and Eleftherios Mylonakis and Mazen Noureddin",

year = "2023",

doi = "10.1016/j.cgh.2023.11.003",

language = "English (US)",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States

T2 - NHANES 2017–2020

AU - Kalligeros, Markos

AU - Vassilopoulos, Athanasios

AU - Vassilopoulos, Stephanos

AU - Victor, David W.

AU - Mylonakis, Eleftherios

AU - Noureddin, Mazen

PY - 2023

Y1 - 2023

UR - http://www.scopus.com/inward/record.url?scp=85180335542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85180335542&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2023.11.003

DO - 10.1016/j.cgh.2023.11.003

M3 - Short survey

C2 - 37949334

AN - SCOPUS:85180335542

SN - 1542-3565

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

ER -

Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this